PRESS RELEASES

Contacts: Marc Viscogliosi, Viscogliosi Bros, LLC (212) 583-9700 ext. 103
Nick Kilsby, EKK PR (203) 406-8800 ext. 21

SPEAKERS TO FOCUS ON REGULATION IN THE MUSCULOSKELETAL SECTOR AND NEW NON-FUSION TECHNOLOGIES AT TWO INVESTOR MEETINGS SPONSORED BY VISCOGLIOSI BROS., LLC


NEW YORK--March 8, 2004--Viscogliosi Bros., LLC (VB), the leading venture capital/private equity and merchant banking firm in the $22.4 billion global musculoskeletal/orthopedics sector, will sponsor two meetings in San Francisco next week for the investment community.

In an evening event on March 11, Christopher Jennings, health care advisor to President Clinton, will address the regulatory and reimbursement environment for new medical device technology under the recently passed Medicare Act. He will be followed by Steve Ubl, the senior government relations executive at AdvaMed, the lobbying group that represents the medical device industry in Washington DC. Anthony Viscogliosi, Senior Managing Partner of VB, will then highlight the recent breakthroughs in non-fusion technology and provide commentary on the future of the industry.

The following morning, on March 12, the CEOs of three venture-backed, international spinal/non-fusion technology companies: Raymedica, Inc., (US); Spine Next SA, (France) and Biorthex, Inc. (Canada) will participate in a panel discussion on market prospects with leading spine surgeons, headed by Dr. Rudolf Bertagnoli, of Germany and Dr. Thierry Marnay.

Both events are admission free and will be held at the W Hotel, San Francisco. The March 11 reception will begin at 5.30 pm in the Great Room located on the third floor of the W and the March 12 reception will begin at 7.30 am in the Industry Room located on the second floor of the W.

About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City, in 1999, VB was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry. Today, VB is a leading independent firm, with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.

As principals of VB, the Viscogliosi brothers have a combined total of more than 35 years experience analyzing and investing in the musculoskeletal/orthopedics sector. They have pioneered innovative financial, strategic and management initiatives for companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
 
> Back to Press Releases

 

Viscogliosi Bros., LLC is not an investment adviser, money manager, asset manager or otherwise give investment advice.